Surgeon Q&A: SAVR and TAVR Insights in 2024 with Dr. Joanna Chikwe

https://www.Heart-Valve-Surgery.com - A new or unexpected diagnosis of a defective or failing aortic valve can be stressful and frightening for patients and their family members. More than anything, the fear often comes from not knowing the next steps for the optimal treatment of life-threatening aortic valve diseases, including aortic stenosis.

During the past 25 years, aortic valve surgery has greatly advanced. There are many treatment options that are safe and effective with minimal risk. For example, there are minimally-invasive transcatheter aortic valve replacement (TAVR) procedures to treat aortic stenosis. While TAVR was initially designed for older, higher-risk patients, this revolutionary therapy is now acceptable for low-risk patients who often go home just one day after the procedure. While TAVR has grown exponentially over the years, many patients are still having their blocked or leaking aortic valves treated surgically, also known as surgical aortic valve replacement (SAVR), using valve repair, valve replacement, valve-sparing and the Ross Procedure.

Patients may wonder what they should know about SAVR and TAVR in 2024. To get the latest patient insights, we interviewed Dr. Joanna Chikwe, a leading aortic valve surgeon and the Chair of Cardiac Surgery at Cedars-Sinai Medical Center in Los Angeles, California. In this video, Dr. Chikwe provides up-to-date research and information about surgical and transcatheter aortic valve replacement.

To schedule an appointment or second opinion with Dr. Joanna Chikwe, please call (866) 345-1289 or visit https://www.heart-valve-surgery.com/s....